Highlights & Happenings
medara Welcomes Leading Advisors to Accelerate Innovation and Impact
At medara, we believe that meaningful innovation happens when deep expertise meets a shared vision to improve patient care. We're thrilled to announce the addition of three exceptional advisors whose experience spans healthcare operations, clinical care, AI, and enterprise strategy, each bringing invaluable perspective to support our mission of transforming cancer risk assessment through imaging and technology.
Dr. David Gruen: A Visionary in Imaging and Women's Health
A nationally recognized radiologist and healthcare executive, Dr. David Gruen brings decades of experience in medical imaging, AI, and digital health innovation. As former Chief Medical Officer for Imaging at IBM Watson Health and Merative, he helped pioneer the future of medical AI. Dr. Gruen has led major women's imaging programs, earned fellow status with the American College of Radiology, and remains a strong advocate for advancing breast imaging nationwide. His deep clinical insights and strategic perspective will help Medara deliver technologies that truly improve patient care.
Mohammad Malik: Bridging Innovation and Real-World Care
With more than 22 years of leadership in healthcare operations, AI deployment, and enterprise strategy, Mohammad Malik joins medara as an advisor committed to making a tangible difference in patient outcomes. At Kaiser Permanente, Mohammad led transformative initiatives that enhanced care for millions—building scalable imaging infrastructure, analytics teams, and AI solutions. Today, he advises healthcare systems, startups, and investors on strategy, implementation, and impact. His passion for bringing innovation to the frontlines of care is a powerful addition to our work at medara.
Professor Mert R. Sabuncu: AI Researcher and Healthcare Problem Solver
Professor Sabuncu is a world-renowned expert in machine learning and medical imaging, leading groundbreaking research at Cornell Tech and Weill Cornell Medicine Radiology. His work focuses on extracting clinical insights from large-scale biomedical data and integrating AI into real-world healthcare applications. With academic roots at Princeton and MIT and a commitment to accelerating innovation at the intersection of AI and medicine, Professor Sabuncu brings a powerful blend of technical vision and translational impact to the medara team.
As we continue to build and validate our AI-powered risk assessment tools, we are honored to have these visionary leaders guiding our work. Together, we're driving forward the future of personalized, imaging-based cancer care—starting with breast cancer.
